Oxidative Medicine and Cellular Longevity / 2017 / Article / Fig 6

Research Article

Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis

Figure 6

Effect of edaravone on alteplase-induced fibrinolysis in PPP. (a) Effects of alteplase (50, 100, or 250 IU/ml) in pooled platelet-poor plasma (). Error bars represent standard deviation. (b) Effects of edaravone (6 or 60 nM), alteplase (100 IU/ml), or their combination on alteplase-induced thrombolysis in pooled PPP (). Error bars represent standard deviation. (c) Measurement of D-dimer concentration to evaluate effects of edaravone (60 nM) on H2O2 (100 μM)-inhibited fibrinolysis by alteplase (100 IU/ml) in pooled PPP (). Error bars represent standard deviation. PPP: platelet-poor plasma; H2O2: hydrogen peroxide.
(a)
(b)
(c)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.